tiprankstipranks
Anavex Life Sciences (GB:0HFR)
LSE:0HFR

Anavex Life Sciences (0HFR) Income Statement

0 Followers

Anavex Life Sciences Income Statement

Last quarter (Q1 2024), Anavex Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Anavex Life Sciences's net income was $-8.62M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 51.67M$ 55.76M$ -50.99M$ 42.00M$ 30.94M$ 28.81M
Operating Income
$ -51.67M$ -55.76M$ -50.99M$ -42.00M$ -30.94M$ -28.81M
Net Non Operating Interest Income Expense
$ 7.04M$ 6.52M$ 4.27M$ 4.63M$ 179.97K$ 56.15K
Other Income Expense
$ -1.83M$ -1.78M-$ -443.83K$ 4.50M$ 2.54M
Pretax Income
$ -43.04M$ -47.50M$ -47.62M$ -37.64M$ -26.26M$ -26.21M
Tax Provision
$ 112.05K$ 7.00K$ 358.49K$ 267.56K$ 22.66K$ 82.18K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -43.16M$ -47.51M$ -47.98M$ -37.91M$ -26.28M$ -26.29M
Basic EPS
$ -0.14$ -0.60--$ -0.45$ -0.54
Diluted EPS
$ -0.14$ -0.60-$ -0.54$ -0.45$ -0.54
Basic Average Shares
$ 401.23M$ 79.79M-$ 69.80M$ 58.19M$ 48.91M
Diluted Average Shares
$ 401.23M$ 79.79M-$ 69.80M$ 58.19M$ 48.91M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 51.67M$ 55.76M$ -50.99M$ 42.00M$ 30.94M$ 28.81M
Net Income From Continuing And Discontinued Operation
$ -43.16M$ -47.51M$ -47.98M$ -37.91M$ -26.28M$ -26.29M
Normalized Income
$ -27.60M$ -37.52M--$ -26.37M$ -26.35M
Interest Expense
------
EBIT
$ -51.05M$ -46.53M$ -48.57M$ -37.67M$ -30.94M$ -28.81M
EBITDA
$ -51.05M$ -46.53M$ -48.57M$ -37.67M$ -30.94M$ -28.81M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis